Chemgineering will carry out a project to rebuild and expand Lomapharm's production. The company, based in Emmerthal, will thus expand and modernize its production capacities.

After the successful completion of the Feasibility Study, Chemgineering International has been also awarded for the Extended Conceptual Design phase for a new high tech investment in the pharmaceutical industry in the South of Europe.

Chemgineering International has successfully completed the Conceptual Design Phase for a new Research & Development Center.

Peter Stromberger and Volker Schöberl have taken over the management of Chemgineering Germany GmbH, replacing Carol Notdurfter, who led the company on an interim basis.

Chemgineering International GmbH is the EPCMV service provider for Maxicells ‘New blood plasma fractionation plant’ in Turkey.

Joining forces

Chemgineering is proud and happy to have made a small contribution to this ambitious and world-changing vaccine project.

The production facility of our customer Liomont in Ocoyoacac, Mexico, planned by IPB-Chemgineering Spain, will be used for the production of Astra Zeneca's COVID-19 vaccine as soon as approval is granted.

The coronavirus is not only currently determining the news situation, but is also presenting us all with new challenges. We have been monitoring the situation very closely from the very beginning and have prepared ourselves.